2/4 2021

We’re going to the US

Fireworks in american colors as we enter the US

It’s been a long time coming, but we finally get to say it out loud; Radiobotics Inc. is now a reality!

Entering the US market is something we have been planning and working on for quite some time and it marks the next logical step for Radiobotics. Our technology has a great potential to help radiologists and orthopedics at hospitals all over the world and we are not shy to admit that we have global growth ambitions. This is why opening an office in the US is a highly strategic and important move for us.

We are already involved in several activities in the US. In March 2020 we were selected to take part in the Texas Medical Center’s accelerator program, TMCx. During the summer of 2020 we we’re introduced to a wide range of specialists, clinicians and several member institutions of TMC. It has truly been a privilege to be part of last year's cohort and this has really shown us that the US is a huge opportunity for us.

We have also established a partnership with vRad (Virtual Radiologic). They are the leading teleradiology practice in the US, the collaboration will strengthen Radiobotics’ capability in quickly developing and validating high quality algorithms within musculoskeletal radiology. This will benefit vRad in providing state-of-the-art teleradiology services. Radiobotics is hereby one of the latest AI vendors to join forces with vRad, in their continuous journey to optimize and revolutionize the workflow of the radiologist.

We have also been busy identifying world class strategic advisors, we began with onboarding Ayse McCracken from eNNOVATE Health Ventures LLC as a strategic advisor. Ayse is an experienced executive and brings a unique combination of business credentials, healthcare industry knowledge, proven success record for driving results, and a transformative mindset to companies aspiring to challenge the healthcare status quo. After serving over three decades as a senior executive in some of the US’s most prominent healthcare systems, Ayse now focuses her knowledge and energy on businesses seeking to revolutionize the delivery of healthcare through eNNOVATE Health Ventures LLC, a consulting firm she started in 2016. This is exactly where she will be supporting Radiobotics, on the path towards challenging the field of Radiology and demonstrating how our new technology can play a crucial role in bringing value to clinicians and their patients, in the American market.

Recently, we have added Nicholas Pachuda to our group of trusted advisors! Nick is a former foot and ankle Surgeon with extensive clinical experience and over 17 years of diverse senior healthcare business management and innovation experience. Most recently, he served as the leader and Worldwide Vice President of Orthopedic Innovation for the Johnson & Johnson Medical Device Group, where he led strategic portfolio planning and external innovation across the global orthopedic franchise. Welcome Nicholas Pachuda, we couldn’t be more proud to have him onboard.

Finally we’re very excited about a new partnership agreement with US based Efferent Health. Efferent Health offers cloud based hybrid systems for medical imaging and clinical operations management. Our partnership will be all about enabling distribution of our products through their channels and we’re looking forward to working with the amazing team.

We are extremely excited about our expansion in the US and we are looking to begin hiring in Q2 for our office in Texas. In this regard we are specifically looking for qualifications within business development, commercialization of innovative healthtech products and ideally a profile who’s also familiar with the radiology and orthopedic space, who will be instrumental in building Radiobotics Inc.